CVS Health Corp. CVS is pulling decongestants off their shelves that contain an ingredient an Food and Drug Administration advisory committee determined did not work, according to a Thursday report from the Wall Street Journal. Used as a key ingredient in decongestants for nearly a century, FDA advisors in September determined that phenylephrine did not improve congestion. While the FDA has not made a decision on the ingredient, CVS said it is voluntarily taking products containing it off their shelves. CVS shares were last up 0.1% in recent activity. Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.Source [MarketWatch.com – MarketPulse](http://www.marketwatch.com/news/story/cvs-voluntarily-pulling-decongestants-shelves/story.aspx?guid=%7B20C06575%2D04D4%2DB545%2D7284%2D201FAE8784D8%7D&siteid=rss)
CVS voluntarily pulling decongestants from shelves that contain ineffective ingredient
Bookmark the permalink.